It is becoming increasingly apparent that the incorrect administration of insulin potentially contributes to an increased risk of unexpected hypoglycemia, glucose variability, and failure to achieve the desired glycemic goal [16,17]. This evidence concerns the gene INS and Hypoglycemia.